Terminated PHASE4 INTERVENTIONAL 3-arm NCT00974922

Vitamin D Deficiency in Patients With Hypertension

Vitamin D Deficiency, Renin Inhibitor Response, and Vitamin D Supplementation in Patients With Hypertension

Sponsor: Novartis

Conditions Hypertension Vitamin D Deficiency

Interventions Aliskiren Cholecalciferol Placebo

Updated 8 times since 2017 Last updated: Feb 9, 2018 Started: Aug 31, 2009 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Administrative/Sponsor Business Decision - terminated - study was not completed

Other terminated trials from Novartis

See all terminations from Novartis

Other Hypertension trials with similar outcome

Browse all Hypertension trials

This PHASE4 trial investigates Hypertension and Vitamin D Deficiency and is currently terminated or withdrawn. Novartis leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 3 earlier versions

Mar 2018 — Jun 2018 [monthly]

Terminated PHASE4
Feb 2017 — Mar 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novartis
UConn Health

Data source: UConn Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Farmington, United States